Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia

British Journal of Haematology

Volumn 175, Issue 2, 2016, Pages 331-338

  Nottage, Kerri A ^a   Ware, Russell E ^b   Aygun, Banu ^c   Smeltzer, Matthew ^d   Kang, Guolian ^a   Moen, Joseph ^a   Wang, Winfred C ^a   Hankins, Jane S ^a   Helton, Kathleen J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Northwell Health   (United States)

^d UNIVERSITY OF MEMPHIS   (United States)

Author keywords

brain MRA; brain MRI; hydroxycarbamide; sickle cell anaemia; silent cerebral infarct

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ARTICLE; BONE MARROW SUPPRESSION; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE EXACERBATION; DRUG DOSE ESCALATION; DRUG EFFICACY; FEMALE; FETUS BLOOD; HEMOGLOBIN BLOOD LEVEL; HUMAN; LABORATORY TEST; LONG TERM CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MAXIMUM TOLERATED DOSE; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; OXYGEN SATURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SICKLE CELL ANEMIA; SILENT CEREBRAL INFARCTION; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; ANEMIA, SICKLE CELL; ASYMPTOMATIC DISEASE; COMPLICATION; DIAGNOSTIC IMAGING; GENETICS; INFANT; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA, SICKLE CELL; ASYMPTOMATIC DISEASES; BRAIN INFARCTION; CHILD; CHILD, PRESCHOOL; FEMALE; FETAL HEMOGLOBIN; HUMANS; HYDROXYUREA; INFANT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; TREATMENT OUTCOME;

EID: 84993960918     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14235     Document Type: Article

References (43)

1. Armstrong, F.D., Thompson, R.J. Jr, Wang, W., Zimmerman, R., Pegelow, C.H., Miller, S., Moser, F., Bello, J., Hurtig, A. & Vass, K. (1996) Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics, 97, (6 Pt 1), 864–870.
2. Aygun, B., Mortier, N.A., Smeltzer, M.P., Hankins, J.S. & Ware, R.E. (2011) Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatric Nephrology(Berlin, Germany), 26, 1285–1290.
3. Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coic, L., Leveille, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galacteros, F., Torres, M., Kuentz, M., Ferry, C., Socie, G., Reinert, P. & Delacourt, C. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood, 117, 1130–1140; quiz 1436.
4. Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Vasile, M., Kasbi, F., Hau, I., Madhi, F., Fourmaux, C., Biscardi, S., Epaud, R. & Pondarre, C. (2015) Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia. Blood, 125, 1653–1661.
5. Cancio, M.I., Helton, K.J., Schreiber, J.E., Smeltzer, M.P., Kang, G. & Wang, W.C. (2015) Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke. British Journal of Haematology, 171, 120–129.
6. DeBaun, M.R., Schatz, J., Siegel, M.J., Koby, M., Craft, S., Resar, L., Chu, J.Y., Launius, G., Dadash-Zadeh, M., Lee, R.B. & Noetzel, M. (1998) Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology, 50, 1678–1682.
7. DeBaun, M.R., Armstrong, F.D., McKinstry, R.C., Ware, R.E., Vichinsky, E. & Kirkham, F.J. (2012a) Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood, 119, 4587–4596.
8. DeBaun, M.R., Sarnaik, S.A., Rodeghier, M.J., Minniti, C.P., Howard, T.H., Iyer, R.V., Inusa, B., Telfer, P.T., Kirby-Allen, M., Quinn, C.T., Bernaudin, F., Airewele, G., Woods, G.M., Panepinto, J.A., Fuh, B., Kwiatkowski, J.K., King, A.A., Rhodes, M.M., Thompson, A.A., Heiny, M.E., Redding-Lallinger, R.C., Kirkham, F.J., Sabio, H., Gonzalez, C.E., Saccente, S.L., Kalinyak, K.A., Strouse, J.J., Fixler, J.M., Gordon, M.O., Miller, J.P., Noetzel, M.J., Ichord, R.N. & Casella, J.F. (2012b) Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood, 119, 3684–3690.
9. DeBaun, M.R., Gordon, M., McKinstry, R.C., Noetzel, M.J., White, D.A., Sarnaik, S.A., Meier, E.R., Howard, T.H., Majumdar, S., Inusa, B.P., Telfer, P.T., Kirby-Allen, M., McCavit, T.L., Kamdem, A., Airewele, G., Woods, G.M., Berman, B., Panepinto, J.A., Fuh, B.R., Kwiatkowski, J.L., King, A.A., Fixler, J.M., Rhodes, M.M., Thompson, A.A., Heiny, M.E., Redding-Lallinger, R.C., Kirkham, F.J., Dixon, N., Gonzalez, C.E., Kalinyak, K.A., Quinn, C.T., Strouse, J.J., Miller, J.P., Lehmann, H., Kraut, M.A., Ball, W.S. Jr, Hirtz, D. & Casella, J.F. (2014) Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. New England Journal of Medicine, 371, 699–710.
10. Dowling, M.M., Quinn, C.T., Plumb, P., Rogers, Z.R., Rollins, N.K., Koral, K. & Buchanan, G.R. (2012) Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease. Blood, 120, 3891–3897.
11. Estepp, J.H., Smeltzer, M.P., Wang, W.C., Hoehn, M.E., Hankins, J.S. & Aygun, B. (2013) Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children. British Journal of Haematology, 161, 402–405.
12. Hankins, J.S., Ware, R.E., Rogers, Z.R., Wynn, L.W., Lane, P.A., Scott, J.P. & Wang, W.C. (2005) Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood, 106, 2269–2275.
13. Hankins, J.S., Aygun, B., Nottage, K., Thornburg, C., Smeltzer, M.P., Ware, R.E. & Wang, W.C. (2014) From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia. Medicine (Baltimore), 93, e215.
14. Heeney, M.M. & Ware, R.E. (2010) Hydroxyurea for children with sickle cell disease. Hematology/Oncology Clinics of North America, 24, 199–214.
15. Helton, K.J., Adams, R.J., Kesler, K.L., Lockhart, A., Aygun, B., Driscoll, C., Heeney, M.M., Jackson, S.M., Krishnamurti, L., Miller, S.T., Sarnaik, S.A., Schultz, W.H. & Ware, R.E. (2014) Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood, 124, 891–898.
16. Hulbert, M.L., McKinstry, R.C., Lacey, J.L., Moran, C.J., Panepinto, J.A., Thompson, A.A., Sarnaik, S.A., Woods, G.M., Casella, J.F., Inusa, B., Howard, J., Kirkham, F.J., Anie, K.A., Mullin, J.E., Ichord, R., Noetzel, M., Yan, Y., Rodeghier, M. & Debaun, M.R. (2011) Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood, 117, 772–779.
17. Kawadler, J.M., Clayden, J.D., Clark, C.A. & Kirkham, F.J. (2016) Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis. Developmental Medicine and Child Neurology, doi:10.1111/dmcn.13113
18. King, A.A., Strouse, J.J., Rodeghier, M.J., Compas, B.E., Casella, J.F., McKinstry, R.C., Noetzel, M.J., Quinn, C.T., Ichord, R., Dowling, M.M., Miller, J.P. & Debaun, M.R. (2014) Parent education and biologic factors influence on cognition in sickle cell anemia. American Journal of Hematology, 89, 162–167.
19. Kinney, T.R., Sleeper, L.A., Wang, W.C., Zimmerman, R.A., Pegelow, C.H., Ohene-Frempong, K., Wethers, D.L., Bello, J.A., Vichinsky, E.P., Moser, F.G., Gallagher, D.M., DeBaun, M.R., Platt, O.S. & Miller, S.T. (1999) Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics, 103, 640–645.
20. Kugler, S., Anderson, B., Cross, D., Sharif, Z., Sano, M., Haggerty, R., Prohovnik, I., Hurlet-Jensen, A., Hilal, S., Mohr, J.P., & DeVivo, D.C. (1993) Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. Archives of Neurology, 50, 629–635.
21. van der Land, V., Hijmans, C.T., de Ruiter, M., Mutsaerts, H.J., Cnossen, M.H., Engelen, M., Majoie, C.B., Nederveen, A.J., Grootenhuis, M.A. & Fijnvandraat, K. (2015) Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease. British Journal of Haematology, 168, 553–556.
22. Madden, N.A., Jones, G.L., Kalpatthi, R. & Woods, G. (2014) Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: a survey of health care providers. Journal of Pediatric Hematology/oncology, 36, e382–e386.
23. Miller, S.T., Macklin, E.A., Pegelow, C.H., Kinney, T.R., Sleeper, L.A., Bello, J.A., DeWitt, L.D., Gallagher, D.M., Guarini, L., Moser, F.G., Ohene-Frempong, K., Sanchez, N., Vichinsky, E.P., Wang, W.C., Wethers, D.L., Younkin, D.P., Zimmerman, R.A. & DeBaun, M.R.; Disease Cooperative Study of Sickle Cell. (2001) Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. Journal of Pediatrics, 139, 385–390.
24. Nottage, K.A., Ware, R.E., Winter, B., Smeltzer, M., Wang, W.C., Hankins, J.S., Dertinger, S.D., Shulkin, B. & Aygun, B. (2014) Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea. European Journal of Haematology, 93, 377–383.
25. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288–294.
26. Pegelow, C.H., Macklin, E.A., Moser, F.G., Wang, W.C., Bello, J.A., Miller, S.T., Vichinsky, E.P., DeBaun, M.R., Guarini, L., Zimmerman, R.A., Younkin, D.P., Gallagher, D.M. & Kinney, T.R. (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood, 99, 3014–3018.
27. Powars, D., Wilson, B., Imbus, C., Pegelow, C. & Allen, J. (1978) The natural history of stroke in sickle cell disease. American Journal of Medicine, 65, 461–471.
28. Prengler, M., Pavlakis, S.G., Prohovnik, I. & Adams, R.J. (2002) Sickle cell disease: the neurological complications. Annals of Neurology, 51, 543–552.
29. Quinn, C.T., McKinstry, R.C., Dowling, M.M., Ball, W.S., Kraut, M.A., Casella, J.F., Dlamini, N., Ichord, R.N., Jordan, L.C., Kirkham, F.J., Noetzel, M.J., Roach, E.S., Strouse, J.J., Kwiatkowski, J.L., Hirtz, D. & DeBaun, M.R. (2013) Acute silent cerebral ischemic events in children with sickle cell anemia. JAMA Neurology, 70, 58–65.
30. Rana, S., Houston, P.E., Surana, N., Shalaby-Rana, E.I. & Castro, O.L. (1997) Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke. Journal of Pediatrics, 131, 757–760.
31. Schatz, J., White, D.A., Moinuddin, A., Armstrong, M. & DeBaun, M.R. (2002) Lesion burden and cognitive morbidity in children with sickle cell disease. Journal of Child Neurology, 17, 891–895.
32. Sheehan, V.A., Crosby, J.R., Sabo, A., Mortier, N.A., Howard, T.A., Muzny, D.M., Dugan-Perez, S., Aygun, B., Nottage, K.A., Boerwinkle, E., Gibbs, R.A., Ware, R.E. & Flanagan, J.M. (2014) Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemia. PLoS One, 9, e110740.
33. Singh, S.A., Koumbourlis, A.C. & Aygun, B. (2008) Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea. Pediatric Blood & Cancer, 50, 1258–1260.
34. Steen, R.G., Emudianughe, T., Hankins, G.M., Wynn, L.W., Wang, W.C., Xiong, X. & Helton, K.J. (2003) Brain imaging findings in pediatric patients with sickle cell disease. Radiology, 228, 216–225.
35. Sumoza, A., de Bisotti, R., Sumoza, D. & Fairbanks, V. (2002) Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA). American Journal of Hematology, 71, 161–165.
36. Wang, W., Enos, L., Gallagher, D., Thompson, R., Guarini, L., Vichinsky, E., Wright, E., Zimmerman, R. & Armstrong, F.D. (2001) Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. Journal of Pediatrics, 139, 391–397.
37. Wang, W.C., Pavlakis, S.G., Helton, K.J., McKinstry, R.C., Casella, J.F., Adams, R.J. & Rees, R.C. (2008) MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatric Blood & Cancer, 51, 643–646.
38. Ware, R.E. (2010) How I use hydroxyurea to treat young patients with sickle cell anemia. Blood, 115, 5300–5311.
39. Ware, R.E. & Helms, R.W. (2012) Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood, 119, 3925–3932.
40. Ware, R.E., Zimmerman, S.A. & Schultz, W.H. (1999) Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood, 94, 3022–3026.
41. Ware, R.E., Zimmerman, S.A., Sylvestre, P.B., Mortier, N.A., Davis, J.S., Treem, W.R. & Schultz, W.H. (2004) Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. Journal of Pediatrics, 145, 346–352.
42. Ware, R.E., Davis, B.R., Schultz, W.H., Brown, R.C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., Luchtman-Jones, L., Rogers, Z.R., Hilliard, L., Gauger, C., Piccone, C., Lee, M.T., Kwiatkowski, J.L., Jackson, S., Miller, S.T., Roberts, C., Heeney, M.M., Kalfa, T.A., Nelson, S., Imran, H., Nottage, K., Alvarez, O., Rhodes, M., Thompson, A.A., Rothman, J.A., Helton, K.J., Roberts, D., Coleman, J., Bonner, M.J., Kutlar, A., Patel, N., Wood, J., Piller, L., Wei, P., Luden, J., Mortier, N.A., Stuber, S.E., Luban, N.L., Cohen, A.R., Pressel, S. & Adams, R.J. (2015) Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet, doi:10.1016/S0140-6736(15)01041-7
43. Yawn, B.P., Buchanan, G.R., Afenyi-Annan, A.N., Ballas, S.K., Hassell, K.L., James, A.H., Jordan, L., Lanzkron, S.M., Lottenberg, R., Savage, W.J., Tanabe, P.J., Ware, R.E., Murad, M.H., Goldsmith, J.C., Ortiz, E., Fulwood, R., Horton, A. & John-Sowah, J. (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA, 312, 1033–1048.